Vonoprazan-based Versus Esomeprazole-based Triple Therapy for Helicobacter Pylori Eradication

NCT07537634 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Helicobacter Pylori Infection
Dyspepsia
Peptic Ulcer Disease
Helicobacter Pylori
H Pylori

Interventions

DRUG: vonoprazan-based triple therapy (VAL regimen)
DRUG: Esomeprazole-based triple therapy (EAL regimen)

Sponsor

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh